EVC Q1 2026 Earnings Strong EPS Drives Stock Higher Amphastar Pharmaceuticals AMPH Q1 2026 Earnings EPS Misses Estimates by 416 as Stock Edges Higher Exicure XCUR Q2 2022 Earnings WiderThanExpected Loss Fails to Deter Investors SPAI Q1 2026 Earnings EPS Misses Estimates Amid Revenue Discontinuation PHGE Q4 2025 Earnings Severe EPS Miss as BiomX Continues Clinical Development ESCA Q1 2026 Earnings EPS Surges 74 Above Estimates Stock Moves Higher